Ibrexafungerp: an orally active β-1,3-glucan synthesis inhibitor
Apgar, James M., Wilkening, Robert R., Parker, Dann L., Meng, Dongfang, Wildonger, Kenneth J., Sperbeck, Donald, Greenlee, Mark L., Balkovec, James M., Flattery, Amy M., Abruzzo, George K., Galgoci, AJournal:
Bioorganic & Medicinal Chemistry Letters
DOI:
10.1016/j.bmcl.2020.127661
Date:
November, 2020
File:
PDF, 462 KB
2020
File converter
More search results
More benefits 
